By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


European Medicines Agency (EMA) 

7 Westferry Circus
Canary Wharf
London    E14 4HB  United Kingdom
Phone: 44-0-20-7523-7600 Fax: n/a



Company News
Regeneron (REGN) And Sanofi (SNY)i Announce Marketing Authorization Application For Dupixent (Dupilumab) Accepted For Review By The EMA 12/8/2016 8:10:29 AM
3D Communications Expands FDA And EMA Regulatory And Scientific Services 11/16/2016 11:43:23 AM
SAGE Therapeutics (SAGE) Release: SAGE-547 Granted PRIME Designation By EMA For The Treatment Of Postpartum Depression 11/16/2016 10:34:30 AM
Albireo (ALBO)’s Lead Product Candidate For Orphan Pediatric Liver Disease Accepted Into EMA's PRIME Program 11/15/2016 8:50:32 AM
GENFIT (ALGFT) Initiates Pediatric NAFLD/NASH Program In Europe Further To The Approval Of Elafibranor’s Pediatric Investigation Plan By The EMA 11/14/2016 9:46:12 AM
CSL Behring Release: AFSTYLA, For Haemophilia A, Receives Positive Opinion From EMA CHMP 11/14/2016 8:48:56 AM
Mylan (MYL) And BioCon (BIOCON.NS) Announce Regulatory Submission For Insulin Glargine Accepted For Review By EMA 11/3/2016 7:37:39 AM
AmpliPhi Bio (APHB) Granted Small And Medium Enterprise Status By EMA 11/1/2016 11:45:25 AM
Can-Fite BioPharma (CFBI) Advances Towards A Pivotal Phase III Clinical Trial In Psoriasis With Piclidenoson (CF101) Following Reaching Agreement With EMA 11/1/2016 6:37:20 AM
Merck KGaA (MKGAF.PK) Release: EMA Validates The Marketing Authorization Application For Avelumab For The Treatment Of Metastatic Merkel Cell Carcinoma 10/31/2016 7:06:24 AM